A pediatric status epilepticus review describes continuous EEG as central to assessing seizure control during anesthetic infusions.
The review discusses progression from obvious convulsive activity toward subtle or absent motor signs during ongoing status epilepticus. For refractory cases treated with agents such as midazolam, it describes titration guided by continuous EEG toward electrographic seizure cessation or burst suppression. Those endpoints require electrical observation rather than an inference from reduced movement alone.
Match infusion changes with the EEG interpretation, clinical examination, and treatment timeline. Sedation depth, visible convulsions, and electrographic seizures answer related but different questions. The review also acknowledges insufficient evidence to standardize the intensity and duration of refractory treatment. It therefore cannot establish that one infusion target guarantees the best outcome for every child. The useful lesson for record analysis is to identify which endpoint was actually observed before declaring treatment success or failure.
Original analysis of the supplied journal article, identified as PMC6982635.